Skip to end of metadata
Go to start of metadata



Dial-in Number

  • One tap mobile
    +13126266799,,3231998494# US (Chicago)
    +13462487799,,3231998494# US (Houston)
  • Dial by your location
    +1 312 626 6799 US (Chicago)
    +1 346 248 7799 US (Houston)
    +1 669 900 6833 US (San Jose)
    +1 929 436 2866 US (New York)
    +1 253 215 8782 US
    +1 301 715 8592 US
    Meeting ID: 323 199 8494
    Find your local number:

Web session

HL7 Antitrust Policy

Professional Associations, such as HL7, which bring together competing entities are subject to strict scrutiny under applicable antitrust laws. HL7 recognizes that the antitrust laws were enacted to promote fairness in competition and, as such, supports laws against monopoly and restraints of trade and their enforcement. Each individual participating in HL7 meetings and conferences, regardless of venue, is responsible for knowing the contents of and adhering to the HL7 Antitrust Policy as stated in §05.01 of the Governance and Operations Manual (GOM).


Please include your organization in your Zoom name.

  • Click on your picture/name in Zoom
  • Click on rename
  • enter <name> - <organization>
Danielle BancroftBest Practice Software
Melva Peters (Scribe)Jenaker Consulting
Jean Duteau (Chair)Duteau Design
John HatemIndependent Consultant (Chair)x
Scott Robertson Kaiser Permanente (Scribe)x
Christof GessnerHL7 Germany
Corey SpearsMITRE
Dave HillMITRE
Frank McKinneyPOCPx
Isaac VetterEpic
Smile Digital Healthx
Lawrence LoColumbia University HIT Student
Margaret WeikerNCPDP
Matt SzczepankiewiczEpic
Peter SergentHL7 New Zealand
Reed D. GelzerTrustworthy EHR
Shelly SpiroPharmacy HIT Collaborativex
Stephen ChuADHA


Tim McNeilSurescriptsx
Kim RobertsPharmacy HIT Collaborativex
Phung Matthews3M
Jack BrashierEpic
Emmanuel Obasuyi

Joel MontavonPQA
Robb YoungPharmID
Christopher Isong

Gary SchoettmerNetRx
Courtney BlandCVS / Aetna
Mark NeumuthAetna
Ed MillikanFDA
Sanket RavalCVS / Aetna
James Tcheng

Peter Muir
Joe KellySurescripts
Peter Jordan

Jose Costa Teixeira
Jeff ShickUSP
Kent BulzaArterax

Agenda Items and Notes

Outstanding Action Item List

Meeting Notes from previous meeting

Project Proposals

Project Proposals in Review 

Project Scope Statements

Project Scope Statements - none to review

External Meeting Review

Catalog Updates (John Hatem)

  • - No meeting last week, next meeting Dec 2

Workflow Update (John Hatem)

    • met today, working through trackers, nothing specific to pharmacy

Healthcare Product Update (John Hatem)

    • met today.  tracker on device property and device metric.  much discussion on when to use which.  'property' is static, 'metric' can change over time.  nothing specific to pharmacy.

EHR conformant reconciled medication list (cRML) (Scott Robertson / John Hatem)

    • nothing to report.  difficult to follow meetings (inconsistent).  There is a desire to set up an HL7 project.

Potential Drug-Drug Interaction (PDDI) CDS IG

NCPDP Updates (NCPDP Members)


Pharmacist Consult Note (Scott)

  • - pre

Pharmacy Templates

  • - Block vote status?
    • John Hatem will follow up with Gorgio for status

Specialty Medication Enrolment IG

Trackers - Pharmacy Tracker Dashboard (see trackers for details / resolutions)

  • FHIR-39319 - Getting issue details... STATUS  
    • discussion tended to not agree with Rik, but the description for Dosage.text needs to be clarified.  Persuasive with Modification.  
    • considerable discussion on what the appropriate description is, what is the intent of Dosage.text
    • an interim definition included in comment, although we are not in full agreement 

Any Other Business

  • discussion on MedicationAdministration.performer.device.  who set the parameters, when set, when changed.
    • Stephen will follow up with Orders

Next meeting: